» Articles » PMID: 18668526

Radiation Modulation of MicroRNA in Prostate Cancer Cell Lines

Overview
Journal Prostate
Date 2008 Aug 1
PMID 18668526
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroRNAs (miRNA) are gene regulators and play an important role in response to cellular stress.

Methods: Using multiplexed quantitative real-time PCR we performed global miRNA screening of prostate cancer cells in response to radiation treatment.

Results: Several miRNA were significantly altered in response to radiation treatment. Significant changes were observed in miR-521 and miR-34c. To determine the role of miR-521 in radiation response we transiently overexpressed miR-521 using miR-521 mimic. The miR-521 mimic significantly sensitized prostate cancer cells to radiation treatment. Conversely, ectopic inhibition of miR-521 resulted in radiation resistance of prostate cancer cells. To determine the mechanism by which miR-521 modulates radiation sensitivity we measured the expression levels of one of its predicted target protein, Cockayne syndrome protein A (CSA). CSA is a DNA repair protein, and its levels correlated inversely with the levels of miR-521. Radiation treatment downregulated the levels of miR-521 and upregulated CSA protein. Similarly, ectopic inhibition of miR-521 resulted in increased CSA protein levels. Therefore by altering the levels of CSA protein, miR-521 sensitized prostate cancer cells to radiation treatment.

Conclusion: miR-521 modulates the expression levels of DNA repair protein, CSA and plays an important role, in the radio-sensitivity of prostate cancer cell lines. Thus miR-521 can be a potential target for enhancing the effect of radiation treatment on prostate cancer cells.

Citing Articles

miRNAs in radiotherapy resistance of cancer; a comprehensive review.

Al-Hawary S, Jasim S, Altalbawy F, Kumar A, Kaur H, Pramanik A Cell Biochem Biophys. 2024; 82(3):1665-1679.

PMID: 38805114 DOI: 10.1007/s12013-024-01329-2.


Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance in Cancer Cells.

Jalali-Zefrei F, Mousavi S, Delpasand K, Shourmij M, Farzipour S Curr Gene Ther. 2024; 25(2):113-135.

PMID: 38676526 DOI: 10.2174/0115665232301727240422092311.


Radiotherapy Metastatic Prostate Cancer Cell Lines Treated with Gold Nanorods Modulate miRNA Signatures.

Soares S, Aires F, Monteiro A, Pinto G, Faria I, Sales G Int J Mol Sci. 2024; 25(5).

PMID: 38474003 PMC: 10931958. DOI: 10.3390/ijms25052754.


Unfolding the Complexity of Exosome-Cellular Interactions on Tumour Immunity and Their Clinical Prospects in Nasopharyngeal Carcinoma.

Chak P, Kam N, Choi T, Dai W, Kwong D Cancers (Basel). 2024; 16(5).

PMID: 38473281 PMC: 10931083. DOI: 10.3390/cancers16050919.


Insights into the radiotherapy-induced deferentially expressed RNAs in colorectal cancer management.

Karimpur Zahmatkesh A, Moqadami A, Khalaj-Kondori M Iran J Basic Med Sci. 2023; 26(12):1380-1389.

PMID: 37970448 PMC: 10634048. DOI: 10.22038/IJBMS.2023.71259.15482.


References
1.
Van Bokhoven A, Varella-Garcia M, Korch C, Johannes W, Smith E, Miller H . Molecular characterization of human prostate carcinoma cell lines. Prostate. 2003; 57(3):205-25. DOI: 10.1002/pros.10290. View

2.
Weidhaas J, Babar I, Nallur S, Trang P, Roush S, Boehm M . MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res. 2007; 67(23):11111-6. PMC: 6070379. DOI: 10.1158/0008-5472.CAN-07-2858. View

3.
Aggarwal B . Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004; 6(3):203-8. DOI: 10.1016/j.ccr.2004.09.003. View

4.
Marsit C, Eddy K, Kelsey K . MicroRNA responses to cellular stress. Cancer Res. 2006; 66(22):10843-8. DOI: 10.1158/0008-5472.CAN-06-1894. View

5.
BOOTSMA D, Weeda G, Vermeulen W, van Vuuren H, Troelstra C, van der Spek P . Nucleotide excision repair syndromes: molecular basis and clinical symptoms. Philos Trans R Soc Lond B Biol Sci. 1995; 347(1319):75-81. DOI: 10.1098/rstb.1995.0012. View